NCT06546033Recruiting
Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis
Determination of the Effects of Intermittent Fasting and Mediterranean Diet on Quality of Life, Circadian Rhythm and Appetite Markers in Patient With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 9 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
When the literature was reviewed, there is no study in which the effects of intermittent fasting and Mediterranean diet on quality of life, sleep, circadian rhythm and appetite hormones leptin and ghrelin levels in MS patients were evaluated and the two diet types were comparatively examined in terms of all these parameters.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- First submitted
- 30 Jul 2024
- Start date
- 2 May 2024
- Primary completion date
- 2 Sept 2026
- Lead sponsor
- Nigde Omer Halisdemir University
- Diseases
- Multiple sclerosis
- NCT number
- NCT06546033
What you commit to
- Study type: Interventional
- Planned participants: 34
- From 2 May 2024 to the primary completion date, 2 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- To have applied any nutritional intervention during the last three months prior to the study,
- To have received cancer treatment and / or to be receiving cancer treatment,
Other illness
- Having a diagnosis of autoimmune system disease that may adversely affect working outside of -MS,
- Diet therapy that has an effect on the autoimmune system within the last three months,
- Being diagnosed with eating behaviour disorder,
- Failure to adapt to the work during the working period, to be in a situation/behaviour that may adversely affect the work,
- Other neurological diseases (e.g. Parkinson's, epilepsy, Alzheimer's),
- Diagnosed with a disease lasting more than 4 months in the last 12 months and other specialised dietary / compositionally different dietary patterns (e.g. high protein, ketogenic, low energy content \< 1000 kcal/day),
Age
- To be in the attack period-Being under 18 years of age and over 65 years of age
Other
- Being in menopause-Mediterranean diet and intermittent fasting feeding programmes within the last three months,
- Having any communication problems,- Not signing the informed consent form,
- Taking supplements such as selenium, zinc, iron, vitamin D and/or B12, which may affect the course of the study,
- Body Mass Index \<18.5 kg/m2 or \>30 kg/m2
- Losing 5% and/or more body weight in the last month,
- Having a physical disability
Who the study is looking for
- To apply to the neurology outpatient clinic, to be a female between the ages of 18-65 who has been diagnosed with MS by a physician
- Not being in the attack period
- Not being in menopause Not being diagnosed with any autoimmune system disease other than -MS that may adversely affect the study,
- Not following the Mediterranean diet and intermittent fasting programmes in the last three months,
- Not being diagnosed with an eating behaviour disorder,
- Not having any communication problems,
- Signing the informed consent form,
- Brain MRI within the last three months,
- Not to be pregnant and lactating
- No physical disability No history of cancer
- Body Mass Index between 18,5 kg/m2- 29,9 kg/m2,
- Not losing 5% and/or more body weight in the last month
Age in the registry: 18 years to 65 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nigde Omer Halisdemir University Coordinator of this site? Confirm its status | Niğde | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.